日本血吸虫幼虫体外移植及吡喹酮治疗前后感染血吸虫小鼠的免疫应答
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
本文旨在探究体外培养日本血吸虫幼虫的新方法、吡喹酮透皮给药药效分析,以及感染日本血吸虫和吡喹酮治疗后宿主的免疫应答反应。不仅为日本血吸虫幼虫的体外操作提供了新方法,也为治疗血吸虫病提供更为便利的治疗途径,同时还探讨了吡喹酮与炎症反应的关系,为吡喹酮作用机理的研究提供了部分理论依据。
     无菌摘取感染日本血吸虫尾蚴42d的BALB/c小鼠肝脏若干,组织均质仪匀浆,恒温孵化毛蚴,将毛蚴与草地夜蛾(Spodoptera frugiperda)卵巢细胞(sf9细胞)于恒温细胞培养箱中共培养。分别拍摄共培养1h、12h、24h及3d毛蚴生长照片。将培养3d的母胞蚴注射于阴性钉螺头足部,80d后观察钉螺逸蚴情况。本试验重复三次,三次试验的钉螺存活率分别为24.72%、28.23 %和57.89%,活螺阳性率分别达4.55%、8.57%和14.29%。上述试验逸出的尾蚴经人工感染BALB/c小鼠,检测尾蚴的活力,同时通过组织化学染色法和PCR方法鉴定尾蚴的相关基因特性。
     BALB/c小鼠经腹部贴片人工感染尾蚴40±2条,感染35d后,按800mg/kg、480mg/kg、240mg/kg经吡喹酮透皮剂各治疗一次,以及240mg/kg透皮3次,腹部透皮治疗小鼠,一周后解剖小鼠,统计减虫率、减肝卵率和减肝脏虫卵孵化率等指标。最高减虫率到达50%以上,800mg/kg透皮剂量的减肝卵率接近70%,各组减雌率均为100%,且减毛蚴孵化率均在50%以上。
     同时,以BALB/c小鼠作为实验动物模型,BALB/c小鼠经腹部贴片人工感染尾蚴30±2条。在感染28d和35d使用吡喹酮口服制剂对其进行定量(900mg/kg)治疗,通过流式细胞术检测各试验组小鼠CD4~+、CD8~+淋巴细胞亚群比例,以及IL-4、IFN-γ、IL-17等细胞因子表达水平的变化。
     试验结果表明,经本试验培养阳性钉螺释放的尾蚴具有感染性,且与日本血吸虫有相同的基因特性。以sf9细胞作为滋养层细胞体外培养毛蚴,通过显微注射获得人工培养阳性钉螺,为日本血吸虫幼虫的体外操作提供了一种新的方法。吡喹酮透皮剂杀灭血吸虫的效果具有剂量和次数依赖性,少量多次的治疗效果较好,各组均达到分离雌雄虫合抱的效果。吡喹酮治疗后,因虫体的死亡引发了一系列炎症反应,诱发了Th1/Th2型混合的细胞免疫应答,其中以Th2型免疫反应为主。Th17细胞在炎症反应中也发挥了重要的作用,吡喹酮对炎症反应可能有抑制作用。
This paper aimed to explore a new method of in vitro cultivation of Schistosoma japonicum larvae,transdermal delivery efficacy of praziquantel,the immune response of the host of Schistosoma japonicum and after treatment with praziquantel. Not only provided a new method of in vitro manipulation of Schistosoma japonicum larvae, but also provided a more convenience therapeutic approach for the treatment of schistosomiasis, explored the relationship between praziquantel and inflammation, in order to provide some theoretical basis for studying the mechanism of praziquantel.
     Several BALB / c mouse`s livers were removed aseptic which were infected by Schistosoma japonicum after 42 days, homogenated by tissue homogenate instrument, incubated miracidium with constant temperature, the miracidium co-cultivated with Spodoptera frugiperda ovary cells (sf9 cells) in constant temperature Cell incubator. The pictures of miracidia were recorded after co-cultivation for 1 h, 12 h, 24 h and 3 d. The co-cultivated for 3 days mother sporocysts injected in the head and foot of negative snails, after 80 days, observed whether cercariae could be obtained or not. The experiment repeated three times, the survival rates of snails in three experiments were 24.72%, 28.23 % and 57.89% respectively while the positive rates of cercariae were 4.55%, 8.57% and 14.29% respectively. The related gene characteristics of cercariae were identified by histochemical examination and PCR method.
     BALB / c mice were infected with Schistosoma japonicum cercariae 40±2.After 35 days, mice were treated with different concentration of PZQ transdermal agent, 800mg/kg, 480mg/kg, 240mg/kg individually, and treated with different times of PZQ transdermal agent, 240mg / kg once and three times individually.percutaneous treatment of abdominal After one week, mice were dissected, statistical of worm reduction rate, egg reduction rate and hatch of egg reduction rate and so on. By treating with 800mg/kg of PZQ transdermal agent, worm reduction rate up to 50%, egg reduction rate up to 70%, and each group of female reduction rate was 100%, miracidia reduction rate up to 50%.
     Meanwhile, BALB/c mice were experimental animal models. BALB / c mice were infected with cercariae 30±2. After 28 days and 35 days of infection, some of mice were treated with praziquantel with quantitative (900mg/kg) by oral approach. After one week or two weeks of treatment, the ratio of CD4+, CD8+ lymphocyte subsets, and the expression levels of cytokines IL-4, IFN -γ, IL-17 were detected by flow cytometry in mice.
     Animal experiments showed that the cercariae released from artificial cultivation of positive snails were infectiuous and had the same gene characteristics of Schistosoma japonicum. Sf9 cells could be feeder cells for in vitro-coltivation of miracidia and positive snails could be obtained by in vitro micro-injection of cercariae thus to provide a new approach for in vitro operation of Schistosoma japonicum larvae. The effect on Schistosoma was depended on dose and times of praziquantel transdermal agent, the better treatment effect was more times and low dose, each group reached the effective of separating the male and female worms. After praziquantel treatment, a series of inflammatory reactions were caused by the death of worm, induced a mixed immune response with Th1/Th2 type, which mainly was Th2 type immune response. Th17 cells also played an important role in the inflammatory response. Praziquantel could inhibit the inflammatory response.
引文
[1]陈龙达,王水清,柳建发.日本血吸虫病防治研究进展[J].地方病通报,2009,4(5):90-91.
    [2]周述龙,林建银,蒋明森.血吸虫学[M].北京科学出版社,2001.
    [3] Katja Kapp,Christine Coustau,Volker Wippersteg,Joseph Jourdane,Werner Kunz, Christoph Grevelding.Transplantation of in vitro-generated Schistosoma mansoni mother sporocysts into Biomphalaria glabrata[J].Parasitology Research, 2003, 91(6): 482–485.
    [4] Pung OJ,Burger AR,Walker MF,Barfield WL,Lancaster MH,Jarrous CE.In vitro cultivation of Microphallus turgidus (Trematoda:microphalldae) from metacercaria to ovigerousadult with continuation of the life cycle in the laboratory[J]. Parasitol, 2009, 95(4): 913–919.
    [5] Johnston DA,Blaxter ML,Degrave WM,et al.Genomics and the biology of parasites[J].Bioessays,1999,21(2):131-147
    [6] Yoshino TP,Dinguirard N,Mour?o Mde M.In vitro manipulation of gene expression in larval Schistosoma:a model for postgenomic approaches in Trematoda [J]. Parasitology, 2010, 137(3):463-483.
    [7]胡昌仁.日本血吸虫的形态、生活史及各期生物学特性[J].实用乡村医生杂志,1995,(1):20-22.
    [8] Rollinson D,Kaukas A,Johnston DA,et al.Some molecular insights into schistosome evolution[J].Int J Parasitol,1997,27(1):11-28.
    [9] Kuwabara PE,Coulson A.RNAi-prospects for a general technique for determining gene function[J].Parasitol Today,2000,16(8):347–349.
    [10] Boyle JP,Wu XJ,Shoemaker CB,Yoshino TP.Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts[J].Mol Biochem Parasitol,2003,128(2):205–215.
    [11] Skelly PJ,Da`dara A,Harn DA.Suppression of cathepsin B expression in Schistosoma mansoni by RNA inte-rference[J].Int J Parasitol,2003,33(4):363–369.
    [12] Wippersteg V,Kapp K,Kunz W,Jackstadt WP,Zahner H,Grevelding CG.HSP70-controlled GFP expression in transiently transformed schistosomes[J]. Mol Biochem Parasitol,2002,120(1):141–150.
    [13] Williams SA,Johnston DA.Helminth genome analysis: the current status of thefilarial and schistosome genome projects[J].Parasitology,1999,118 Suppl:S19–38.
    [14] Franco GR,Valadao AF,Azevedo V,Rabelo EM.The Schistosoma gene discovery program: state of the art[J].Int J Parasitol,2000,30(4):453–463.
    [15] Coustau C,Ataev G,Jourdane J,Yoshino TP.Schistosoma japonicum:In Vitro Cultivation of Miracidium to Daughter Sporocyst Using a Biomphalaria glabrata Embryonic Cell Line[J].Experimental Parasitol,1997,87(2):77–87.
    [16] Coustau C,Yoshino TP.Flukes without snails:advances in the in vitro cultivation of intramolluscan stages of trematodes[J].Experimental.Parasitol,2000,94(1):62–66.
    [17] B Fried.Chemical communication in hermaphroditic digenetic trematodes[J].Journal of Chemical Ecology,1986,12(8):1659–1676.
    [18]方会龙,曾庆仁,王俊杰,曾铁兵,喻容,杨胜辉,刘碧源,刘彦,蔡力汀.日本血吸虫不同发育阶段形态与生长速度差异分析[J].中国病原生物学杂志,2010,5(6):437-439.
    [19]李龙.抗血吸虫病药物的研究现状[J].兽医导刊,2009,(8):5-8.
    [20]李朝晖,董兴齐.血吸虫病治疗药物研究进展[J].中国血吸虫病防治杂志,2009,21(4):334-336.
    [21] Li YS,Ross AG,Sleigh AC,et al.Antibody isotype responses:Infection and reinfection for Schistosoma japonieum in a marshland Area of China[J].Acta TroP, 1999, 73(2): 79-92.
    [22] Webster M,Libranda-Ramirez BD,Aligui GD,et al.The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma joponicum in human populations in Kenya and the philippines[J]..Parasitology,1997,114(Pt 4):383-393.
    [23]刘凡,尹慧彬,苏川.Th-17细胞在寄生虫感染免疫中的作用[J].中国寄生虫学与寄生虫病杂志,2008,26(5):382-386.
    [24] Anne Cooke.Th 17 Cells in Inflammatory Conditions[J].Rev Diabetic stud, 2006, 3(2): 72-75.
    [25]韩根成,沈倍奋.Th17细胞分化、调节及效应研究进展[J].生物化学与生物物理进展,2008,35(2):117-123.
    [26] Yoichiro Iwakura,Harumichi Ishigame.The IL-23/IL-17 axis in inflammation[J].The Journal of Clinical Investigation,2006,116(5):1218-1222.
    [27] Rudner XL,Happel KI,Young EA,and Shellito JE.Interleukin-23(IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection[J].Infect Immun, 2007, 75(6)3055-3061.
    [28] Rutitzky LI,Stadecker MJ.CD4 T cells producing pro-inflammatory interleukin-17mediate high pathology in schistosomiasis[J].Mem Inst Oswaldo Cruz,2006,101 Suppl 1:327-330..
    [29]赵婷,侯孟君,肖勇梅等.ERK1/2和P38信号通路在瘦素诱导巨噬细胞TNF-α表达中的作用[J].中山大学学报(医学科学版),2006,27(5):500-505.
    [30]周菊,韦嘉.MAPK p38信号通路和病毒性乙型肝炎[J].医学信息:下旬刊,2009,1(4):17-18.
    [31]李娜,曹书华.NF-κB在机体炎症与免疫反应中作用的研究进展.中华急诊医学杂志,2007,16(4):442-444.
    [32] Dardalhon V,Korn T,Kuchroo VK,Anderson AC.Role of Th1 and Th17 cells in organ-specific autoimmunity[J].Journal of Autoimmun,2008,31(3):252–256.
    [33] Komiyama Y,Nakae S,Matsuki T,Nambu A,Ishigame H,Kakuta S,Sudo K,Iwakura Y.IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis[J].J Immunol,2006;177(1):566-573.
    [34] Luger D,Silver PB,Tang J,Cua D,Chen Z,Iwakura Y,Bowman EP,Sgambellone NM,Chan CC,Caspi RR. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction aff ect dominant effector category[J].J Exp Med, 2008, 205(4): 799–810.
    [35] Nakae S,Nambu A,Sudo K,and Iwakura Y.Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice[J].J Immunol, 2003, 171(1): 6173-6177.
    [36] Voge M,Seidel JS.Transformation in vitro of miracidia of Schistosoma mansoni and S. japonicum into young sporocysts[J].J Parasitol,1972,58(4):699-704.
    [37] DiConza JJ,Hansen EL.Cultivation of daughter sporocysts in arthropod tissue cultures[J].J Parasitol,1973,59(1):211-212.
    [38] Hansen EL,Perez-Mendez G,Yarwood E.Schistosoma mansoni: Axenic culture of daughter sporocysts[J].Exp Parasitol,1974,36(1):40-44.
    [39] Rashed AA,Shehata KK,James BL,Nasr ME.Axenic in vitro culture of Schistosoma mansoni miracidia[J].J Egypt Soc Parasitol,1996,26(3):575-584.
    [40] Yoshino TP,Laursen JR.Production of Schistosoma mansoni daughter sporocysts from mother sporocysts maintained in synxenic culture with Biomphalaria glabrata embryonic (Bge) cells[J].The Journal of Parasitol,1995,81(5):714–722.
    [41] Eli Chernin.Transplatation of larval Schistosoma mansoni from infected to uninfected snails[J].The journal of Parasitol,1966,52(3):473-482.
    [42] Jourdane J,Theron A.Schistosoma mansoni:Cloning by microsurgical transplantation of sporocysts[J].Experimental Parasitol,1980,50(3):349-357.
    [43] Stibbs HH,Owczarzak SA,Bayne CJ,DeWan P.Schistosome sporocyst-killing amoebae isolated from Biomphalaria glabrata[J].J Invertebrate Pathol, 1979, 33(2): 159–170.
    [44] Ivanchenko MG,Lerner JP,McCormick RS,Toumadje A,Allen B,Fischer K,Hedstrom O,Helmrich A,Barnes DW,Bayne CJ.Continuous in vitro propagation and differentiation of cultures of the intramolluscan stagesof the human parasite Schistosoma mansoni[J].Proc Natl Acad Sci U S A ,1999,96(9):4965–4970.
    [45] Jourdane J,Liang YS,Bruce JI.Transplantation of Schistosoma japonicum daughter sporocysts in Oncomelania hupensis[J].Paraitology,1985,71(2):244-247.
    [46] Davis A,Wegner DH.Multicentre trials of praziquantel in human schistosomiasis: design and techniques[J].Bull World Helath Organ, 1976, 57(5): 767-771.
    [47] Davis A,Biles JE,Ulrich AM.Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium[J].Bull World Helath Organ,1979,57(5):773-779.
    [48] Ishizaki T,Kamo E,Boehme K.Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infection[J].Bull World Helath Organ,1979,57(5):787-791.
    [49] Katz N,Rocha RS,Chaves A.Preliminary trials with praziquantel in human infection due to Schistosoma mansoni[J].Bull World Helath Organ,1979,57(5):781-785.
    [50] Santos AT,Blas BL,Nosenas JS,Portillo GP,Ortega OM,Hayashi M,Boehme K.Preliminary clinical trials with Schistosoma japonicum infection in the Philippines[J]. Bull World Helath Organ,1979,57(5):793-79 9.
    [51]肖树华,邵葆若,郭惠芬,徐月琴,王翠英,焦佩英,哈淑华.用生物鉴定法观察抗血吸虫新药吡喹酮在家兔体内的吸收、分布和排泄[J].药学学报,1980,15(3):135-141.
    [52]肖树华,邵葆若,徐月琴,潘秋如.吡喹酮对血吸虫的作用及其对雌虫排卵和毛蚴孵出的影响[J].中华医学杂志,1980,60(2):137-141.
    [53] Da Silva SP,Noel F.Praziquantel inhibits Schistosoma mansoni attachment in vitro[J].Braz J Med Biol Res,1990,23(10):1005-1008.
    [54]刘湘新,肖洪波,孙志良.吡喹酮脂质体的制备及包封率测定[J].湖南农业大学学报,1998,24(3):251-253.
    [55]陆彬,钟洪兰,杨红.吡喹酮微囊的研制[J].中国医药工业杂志,1997,28(4):159-253.
    [56]杨元清,杨惠中,乐文菊.吡喹酮实验治疗家兔血吸虫病肝硬化的形态学观察[J].中国医学科学院学报,1982,4(1):37-39.
    [57]赵雪云,陈静卿,蒋明森,等.吡喹酮对感染血吸虫小鼠血清羟脯氨酸及肝脏虫卵肉芽肿作用的探讨[J].中国血吸虫病防治杂志,1995,7(3):145-148.
    [58]邱东川,张桂盛,文松,等.日本血吸虫病所致肝纤维化化疗后转归的观察[J].中国血吸虫病防治杂志,2000,12(3):138-140.
    [59]黄一心.吡喹酮是否具有免疫调节作用[J].中国血吸虫病防治杂志,2007,19(1):76-77.
    [60]许馨予,赵嘉庆,迟莹,贺蕾,温小云,苏川.慢性日本血吸虫感染C57BL/6小鼠体内Th1/Th2细胞凋亡的检测[J].中国血吸虫病防治杂志,2008,1(20):8-11.
    [61]陈辉,何立,宗红英,蒋明森,杨孟祥,张培喜.日本血吸虫感染新模型小鼠IFN-γ和IL-4 mRNA的动态变化[J].中国人兽共患病学报,2008,24(4):316-318,337.
    [62]李蓓,王敏.CD4+T细胞的新成员:Th17细胞[J].生命的化学, 2009, 29(2): 172-175.
    [63]温小云,迟莹,贺蕾,周莎,朱继峰,张萃,刘丰,苏川.IL-17对日本血吸虫感染抗体及Th应答的影响[J].中国血吸虫病防治杂志,2009,21(5):373-377.
    [64] Rutitzky LI,Stadecker MJ.CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis[J].Mem Inst Oswaldo Cruz,Rio de Janeiro,,2006,101 Suppl 1: 327-330.
    [65]李龙.抗血吸虫病药物的研究现状[J].兽医导刊,2009,(8):5-8.
    [66]陈名刚.国外吡喹酮防治血吸虫病的进展[J].国际医学寄生虫病杂志,2006,33(1):20-27.
    [67] Arthr MJ,FibrogenesisⅡ.Metalloproteinases and their inhibitors in liver fibrosis[J].Am J Physiol Gastrointest Liver Physiol,2000,279(2):G245-249.
    [68] McCrudden R,Iredale JP.Liver fibrosis,the hepatic stellate cell and tissue inhibitors of metalloproteinases[J].Histol Histopathol,2000,15(4):1159-1168.
    [69] Singh KP,Gerard HC,Hudson AP,Boros DL.Expression of metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice[J].Immunology,2004,111(3):343-352.
    [70] Dunne DW,Butterworth AE,Fulford AJ,et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection[J].Eur J Immunol,1992;22(6):1483–1494.
    [71] Woolhouse ME,Hagan P.Seeking the ghost of worms past[J].Nat Med, 1999, 5 (11): 1225–1227.
    [72] Karanja DM,Hightower AW,Colley DG,et al.Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study [J]. Lancet, 2002, 360(9333):592–596.
    [73] Joseph S,Jones FM,Walter K,Fulford AJ,Kimani G,Mwatha JK,Kamau T,KariukiHC,Kazibwe F,Tukahebwa E,Kabatereine NB,Ouma JH,Vennervald BJ,Dunne DW.Increases in Human T Helper 2 Cytokine Responses to Schistosoma mansoni Worm and Worm-Tegument Antigens Are Induced by Treatment with Praziquantel[J]. J Infect Dis,2004,190(4):835-842.
    [74]王文实,李雍龙.日本血吸虫感染过程中宿主CD4+、CD8+ T细胞凋亡相关基因转录水平的研究[J].中国血吸虫病防治杂志,2001,13(1):14-17.
    [75] Vogelstein B.First p53 relative may be a new tumor suppressor [J]. Science, 1997, 277 (12):1605-1609.
    [76] Hassan MM,Ramadan MA,Mostafa NE,et al.Different cytokines profiles in spleen cells and liver granuloma of Schistosoma mansoni experimentally infected mice during disease development[J].J Egypt Soc Parasitol,2000,30(1):245-256.
    [77] Kaplan MH,Whitfield JR,Boros DL,et al.Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response[J].J Immunol,1998,160(4):1850-1856.
    [78] Harrington LE,Mangan PR,Weaver CT.Expanding the effector CD4+T cell repertoire: the Th17 lineage [J].Curr Op in Immunol,2006,18(3):349-356.
    [79] Kolls JK,Lindén A.Interleukin-17 family members and inflammation[J]. Immunity, 2004, 21(4):467-476.
    [80] Komiyama YS,Nakae T,Matsuki A,et al.IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis[J].J Immunol, 2006, 177(1):566-573.
    [81] Chen Y,Thai P,Zhao Y H,et al.Stimulation of airway mucingene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop[J].J Biol Chem, 2003, 278(19):17036-17043.
    [82] Wong CK,Ho CY,Li EK,et al.Elevation of proinflammatory cytokine (IL-18,IL-17,IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus[J].Lupus,2000,9(8):589-593.
    [83] Yoshida S,Haque A,Mizobuchi T,et al.Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healelung transplants[J].Am J Transp lant,2006,6(4):724-735.
    [84] Rutitzky LI,Lopes da Rosa JR,Stadecker MJ.Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17[J].J Immunol,2005,175(6):3920-3926.
    [85]何毅勋,马金鑫.日本血吸虫毛蚴的扫描电镜观察[J].动物学报. 1981, 27(4): 301-303.
    [86]许世锷.日本血吸虫卵、毛蚴及尾蚴的扫描电镜观察[J].寄生虫学与寄生虫病杂志,1983,1(4):15.
    [87] Voge M,Seidel JS.Transformation in vitro of miracidia of Schistosoma mansoni and Schistosoma japonicum into young sporocysts[J].Parasitol,1972,58(4):699-704.
    [88]董惠芬,蒋明森,李瑛等.日本血吸虫细胞培养方法初探[J].水生生物学报,1995,19(4):382-383.
    [89]董惠芬,蒋明森,李瑛等.日本血吸虫培养细胞形态的初步观察[C].中国动物学会寄生虫专业学会成立10周年纪念论文集,中国科技出版社,1995,131-133.
    [90]董惠芬,蒋明森,李瑛等.日本血吸虫成虫细胞培养条件的初步探讨[J].中国血吸虫病防治杂志,1995,7(5):257-261.
    [91]陈晓蓓,董惠芬,蒋明森等.正交试验法研究日本血吸虫童虫细胞的培养条件[J].中国人畜共患病杂志,1997,13(2):41-42.
    [92]陈晓蓓,董惠芬,蒋明森等.日本血吸虫童虫培养细胞形态的初步观察[J].湖北医科大学学报,1997,18(1):7-9.
    [93]梅柏松,周述龙.渗透压、pH值对日本血吸虫毛蚴体外转变成母胞蚴的影响[J].湖北医学院学报,1988,3(9):200-204.
    [94]王健,周述龙.血吸虫体外培养技术在药物学研究中的应用[J].国际医学寄生虫病杂志,1985,99(1):3-6.
    [95]方正明.血吸虫尾蚴染色玻片标本制作的改进方法[J].中国寄生虫病防治杂志,1999,12(4):255.
    [96] Xia MY,Jourdane J.Penetration and migration routes of Schistosoma japonicum miracidia in the snail Onco-melania hupensis[J].Parasitology,1991,103(1):77-83.
    [97]舒利民.日本血吸虫毛蚴对钉螺的钻穿及在钉螺体内的分布和移行[J].动物学报.2000,46(3):249-254.
    [98]黄一心.吡喹酮抗血吸虫作用机理的奥秘[J].中国血吸虫病防治杂志,2010,22(2):101-104.
    [99]郑新生,郑新安,黄静,段存争,姚宝安.高浓度吡喹酮溶液的透皮吸收及对日本血吸虫病鼠的治疗试验[J].中国药学杂志,2007,42(6):450-453.
    [100]肖树华,邵葆若,徐月琴.吡喹酮对体外培养的日本血吸虫的作用[J].药学学报,1980,15(2):105-107.
    [101]王敏霓,刘约翰,芦仙娥,孙云松.国产吡喹酮杀日本血吸虫体外试验[J].重庆医科大学报,1980(1):64-67.
    [102]尤纪青,梅静艳,肖树华.吡喹酮与篙甲醚合并治疗小鼠血吸虫病的效果观察[J].中国寄生虫病防治杂志,1994,7(1):50-51.
    [103]沈蕾,吴海玮,张兆松,Rosemary Weir,邵莉君,谢彰武,胡林生,陈淑贞,苏川,Yaobi Zhang Martin G Taylor,吴观陵.日本血吸虫病流行区人群吡喹酮治疗前后细胞因子水平的研究[J].中国寄生虫学与寄生虫病杂志,2000,18(1):14-17.
    [104] Rumbley CA,Zekavat SA,Sugaya H·The schistosome granuloma: characterization of lymphocyte migration, activation,and cytokine production[J]..J Immunol, 1998, 161(8): 4129-4137.
    [105] Hogan LH,Wang M,Suresh M,et al.CD+4 TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas[J].J Immunol,2002,169(11):6386-6393.
    [106]肖树华,杨元清,杨惠中,郭惠芳,邵葆若.吡喹酮引起的日本血吸虫体表皮层的损害和宿主白细胞侵入虫体的观察[J].药学学报,1983,18(4):241-246.
    [107] Abbas AK,Murphy KM,Sher A.Functional diversity of helper T lymphocytes [J]. Nature,1996,383(6607): 787-793.
    [108] Hayashia K,Altman A.Protein kinase C theta (PKC-θ) A key player in T cell life and death[J].Pharmacol Res,2007,55(6):537-544.
    [109] Wilson MS,Mentink-Kane MM,Pesce JT,et al.Immunopathology of schistosomiasis [J]. Immunol Cell Biol,2007,85(2):148-154.